Back to Search Start Over

Involvement of anti-inflammatory, antioxidant, and BDNF up-regulating properties in the antipsychotic-like effect of the essential oil of Alpinia zerumbet in mice: a comparative study with olanzapine.

Authors :
de Araújo, Fernanda Yvelize Ramos
Chaves Filho, Adriano José Maia
Nunes, Adriana Mary
de Oliveira, Gersilene Valente
Gomes, Patrícia Xavier Lima
Vasconcelos, Germana Silva
Carletti, Jaqueline
de Moraes, Manoel Odorico
de Moraes, Maria Elisabete
Vasconcelos, Silvânia Maria Mendes
de Sousa, Francisca Cléa Florenço
de Lucena, David Freitas
Macedo, Danielle S.
Source :
Metabolic Brain Disease. Dec2021, Vol. 36 Issue 8, p2283-2297. 15p.
Publication Year :
2021

Abstract

The current drug therapy for schizophrenia effectively treats acute psychosis and its recurrence; however, this mental disorder's cognitive and negative symptoms are still poorly controlled. Antipsychotics present important side effects, such as weight gain and extrapyramidal effects. The essential oil of Alpinia zerumbet (EOAZ) leaves presents potential antipsychotic properties that need further preclinical investigation. Here, we determined EAOZ effects in preventing and reversing schizophrenia-like symptoms (positive, negative, and cognitive) induced by ketamine (KET) repeated administration in mice and putative neurobiological mechanisms related to this effect. We conducted the behavioral evaluations of prepulse inhibition of the startle reflex (PPI), social interaction, and working memory (Y-maze task), and verified antioxidant (GSH, nitrite levels), anti-inflammatory [interleukin (IL)-6], and neurotrophic [brain-derived neurotrophic factor (BDNF)] effects of this oil in hippocampal tissue. The atypical antipsychotic olanzapine (OLZ) was used as standard drug therapy. EOAZ, similarly to OLZ, prevented and reversed most KET-induced schizophrenia-like behavioral alterations, i.e., sensorimotor gating deficits and social impairment. EOAZ had a modest effect on the prevention of KET-associated working memory deficit. Compared to OLZ, EOAZ showed a more favorable side effects profile, inducing less cataleptic and weight gain changes. EOAZ efficiently protected the hippocampus against KET-induced oxidative imbalance, IL-6 increments, and BDNF impairment. In conclusion, our data add more mechanistic evidence for the anti-schizophrenia effects of EOAZ, based on its antioxidant, anti-inflammatory, and BDNF up-regulating actions. The absence of significant side effects observed in current antipsychotic drug therapy seems to be an essential benefit of the oil. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08857490
Volume :
36
Issue :
8
Database :
Academic Search Index
Journal :
Metabolic Brain Disease
Publication Type :
Academic Journal
Accession number :
153497426
Full Text :
https://doi.org/10.1007/s11011-021-00821-5